336 related articles for article (PubMed ID: 25030429)
1. Emerging role of epigenetics in systemic sclerosis pathogenesis.
Ciechomska M; van Laar JM; O'Reilly S
Genes Immun; 2014 Oct; 15(7):433-9. PubMed ID: 25030429
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
[TBL] [Abstract][Full Text] [Related]
3. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics and systemic sclerosis.
Altorok N; Kahaleh B
Semin Immunopathol; 2015 Sep; 37(5):453-62. PubMed ID: 26162437
[TBL] [Abstract][Full Text] [Related]
5. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.
Broen JC; Radstake TR; Rossato M
Nat Rev Rheumatol; 2014 Nov; 10(11):671-81. PubMed ID: 25136786
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic abnormalities in systemic sclerosis.
Makino T; Jinnin M
J Dermatol; 2016 Jan; 43(1):10-8. PubMed ID: 26782002
[TBL] [Abstract][Full Text] [Related]
7. [Systemic sclerosis. Part 2. Epigenetic factors in the pathogenesis of clinical manifestations].
Fryc J; Midro AT; Panasiuk B; Sierakowski S
Przegl Lek; 2015; 72(1):25-30. PubMed ID: 26076574
[TBL] [Abstract][Full Text] [Related]
8. The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target.
Henderson J; Distler J; O'Reilly S
Trends Mol Med; 2019 May; 25(5):395-411. PubMed ID: 30858032
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Zhang Z; Zhang R
Autoimmun Rev; 2015 Oct; 14(10):854-63. PubMed ID: 26026695
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.
Aslani S; Sobhani S; Gharibdoost F; Jamshidi A; Mahmoudi M
Hum Immunol; 2018 Mar; 79(3):178-187. PubMed ID: 29330110
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic factors as drivers of fibrosis in systemic sclerosis.
Bergmann C; Distler JH
Epigenomics; 2017 Apr; 9(4):463-477. PubMed ID: 28343418
[TBL] [Abstract][Full Text] [Related]
12. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
13. Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential.
Tsou PS; Varga J; O'Reilly S
Nat Rev Rheumatol; 2021 Oct; 17(10):596-607. PubMed ID: 34480165
[TBL] [Abstract][Full Text] [Related]
14. New insights into the genetics and epigenetics of systemic sclerosis.
Angiolilli C; Marut W; van der Kroef M; Chouri E; Reedquist KA; Radstake TRDJ
Nat Rev Rheumatol; 2018 Nov; 14(11):657-673. PubMed ID: 30305700
[TBL] [Abstract][Full Text] [Related]
15. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
Luo Y; Xiao R
Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease.
Karami J; Aslani S; Tahmasebi MN; Mousavi MJ; Sharafat Vaziri A; Jamshidi A; Farhadi E; Mahmoudi M
Immunol Cell Biol; 2020 Mar; 98(3):171-186. PubMed ID: 31856314
[TBL] [Abstract][Full Text] [Related]
17. Non-Coding RNA in Systemic Sclerosis: A Valuable Tool for Translational and Personalized Medicine.
Rusek M; Krasowska D
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573278
[TBL] [Abstract][Full Text] [Related]
18. The epigenetic mechanism for discordance of autoimmunity in monozygotic twins.
Xiang Z; Yang Y; Chang C; Lu Q
J Autoimmun; 2017 Sep; 83():43-50. PubMed ID: 28412046
[TBL] [Abstract][Full Text] [Related]
19. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation as a therapy in systemic sclerosis.
O'Reilly S
Rheumatology (Oxford); 2019 Feb; 58(2):191-196. PubMed ID: 29579252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
